Citations (42)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Chao Zhang, Haiyan Li, Xin Xiong, Suodi Zhai, Yudong Wei, Shuang Zhang, Yuanyuan Zhang, Lin Xu & Li Liu. (2017) An open-label, two-period comparative study on pharmacokinetics and safety of a combined ethinylestradiol/gestodene transdermal contraceptive patch. Drug Design, Development and Therapy 11, pages 725-731.
Read now
Read now
Nathalie Chabbert-Buffet, Christian Jamin, Iñaki Lete, Paloma Lobo, Rossella E. Nappi, Axelle Pintiaux, Günther Häusler & Christian Fiala. (2017) Missed pills: frequency, reasons, consequences and solutions. The European Journal of Contraception & Reproductive Health Care 22:3, pages 165-169.
Read now
Read now
K. Waellnitz, I. Duijkers, C. Klipping, T. Rautenberg, B. Rohde & C. Zurth. (2016) A two-centre, open-label, randomised study of ovulation inhibition with three transdermal contraceptive patches, each containing different amounts of ethinyl estradiol and gestodene in healthy, young women. Journal of Obstetrics and Gynaecology 36:1, pages 106-113.
Read now
Read now
Robin Kroll, Larry Seidman, Nancy Ricciotti, Brandon Howard & Herman Weiss. (2015) A phase 1, multicentre, open-label study to evaluate ovarian follicular activity and hormone levels with an extended-regimen combined oral contraceptive with low-dose ethinyl estradiol supplementation. The European Journal of Contraception & Reproductive Health Care 20:4, pages 249-258.
Read now
Read now
Diana Mansour. (2014) International survey to assess women’s attitudes regarding choice of daily versus nondaily female hormonal contraception. International Journal of Women's Health 6, pages 367-375.
Read now
Read now
ChristineL. Hitchcock. (2008) Elements of the Menstrual Suppression Debate. Health Care for Women International 29:7, pages 702-719.
Read now
Read now
M. St Leger Dowse, A. Gunby, R. Moncad, C. Fife, G. Smerdon & P. Bryson. (2007) The combined oral contraceptive pill and the assumed 28-day cycle. Journal of Obstetrics and Gynaecology 27:5, pages 481-484.
Read now
Read now
Articles from other publishers (35)
Russell D. Bradford, Sarah J. Farnsworth, Irene Laurora, Stephanie Sober, Hélène Guillard, Anna Glasier & Saul Shiffman. (2022) Adherence among a cohort taking progestin-only pills prescribed by a healthcare provider: Results of the BENCHMARK study. Contraception 112, pages 48-53.
Crossref
Crossref
E Anne MacGregor & John Guillebaud. (2018) The 7-day contraceptive hormone-free interval should be consigned to history. BMJ Sexual & Reproductive Health 44:3, pages 214-220.
Crossref
Crossref
S O Dubrovina. (2018) Topical issues in combined oral contraceptives usage. Gynecology 20:2, pages 60-63.
Crossref
Crossref
R. Gabriel & A. Fevre. (2017) Anticoncepción estroprogestágena. EMC - Ginecología-Obstetricia 53:3, pages 1-12.
Crossref
Crossref
Pilar Carrasco-Garrido, Ana López de Andrés, Valentín Hernández-Barrera, Isabel Jiménez-Trujillo, Mercedes Esteban-Peña, Napoleón Pérez-Farinós & Rodrigo Jiménez-García. (2016) Trends in the use of oral contraceptives among adolescents and young women in Spain. Reproductive Health 13:1.
Crossref
Crossref
Katarzyna Stawarz, Marcela D Rodríguez, Anna L Cox & Ann Blandford. (2016) Understanding the use of contextual cues: design implications for medication adherence technologies that support remembering. DIGITAL HEALTH 2, pages 205520761667870.
Crossref
Crossref
Julia Winkler, Mark Goldammer, Matthias Ludwig, Beate Rohde & Christian Zurth. (2014) Pharmacokinetic drug?drug interaction between ethinyl estradiol and gestodene, administered as a transdermal fertility control patch, and two CYP3A4 inhibitors and a CYP3A4 substrate. European Journal of Drug Metabolism and Pharmacokinetics 40:4, pages 389-399.
Crossref
Crossref
Christian Zurth, Barbara Schuett, Manuela Casjens, Matthias Ludwig & Katrin Waellnitz. (2015) Pharmacokinetics and adhesion of a transdermal patch containing ethinyl estradiol and gestodene under conditions of heat, humidity, and exercise: A single-center, open-label, randomized, crossover study. Clinical Pharmacology in Drug Development 4:4, pages 245-255.
Crossref
Crossref
Larry Seidman, Robin Kroll, Brandon Howard, Nancy Ricciotti, Jennifer Hsieh & Herman Weiss. (2015) Ovulatory effects of three oral contraceptive regimens: a randomized, open-label, descriptive trial. Contraception 91:6, pages 495-502.
Crossref
Crossref
M. Merz, R. Kroll, R. Lynen & K. Bangerter. (2015) Bleeding pattern and cycle control of a low-dose transdermal contraceptive patch compared with a combined oral contraceptive: a randomized study. Contraception 91:2, pages 113-120.
Crossref
Crossref
D. Gruber, A. Sk?iv?nek, M. Serrani, V. Lanius & M. Merz. (2015) A comparison of bleeding patterns and cycle control using two transdermal contraceptive systems: a multicenter, open-label, randomized study. Contraception 91:2, pages 105-112.
Crossref
Crossref
Inka Wiegratz, Susana Bassol, Edith Weisberg, Uwe Mellinger & Martin Merz. (2014) Effect of a Low-Dose Contraceptive Patch on Efficacy, Bleeding Pattern, and Safety: A 1-Year, Multicenter, Open-Label, Uncontrolled Study. Reproductive Sciences 21:12, pages 1518-1525.
Crossref
Crossref
Alison Edelman, Elizabeth Micks, Maria F Gallo, Jeffrey T Jensen & David A Grimes. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
Martin Merz & Julia Grunert. (2014) Effects of an Ethinyl Estradiol/Gestodene Transdermal Contraceptive Patch on the Endometrium: A Single-Center, Uncontrolled Study. Women's Health 10:1, pages 37-43.
Crossref
Crossref
Txantón Martínez-Astorquiza-Ortiz de Zarate, Teresa Díaz-Martín & Txantón Martínez-Astorquiza-Corral. (2013) Evaluation of factors associated with noncompliance in users of combined hormonal contraceptive methods: a cross-sectional study: results from the MIA study. BMC Women's Health 13:1.
Crossref
Crossref
Wolfgang Junge, Doris Heger-Mahn, Dietmar Trummer & Martin Merz. (2013) Investigation of the Hemostatic Effect of a Transdermal Patch Containing 0.55 mg Ethinyl Estradiol and 2.1 mg Gestodene Compared with a Monophasic Oral Contraceptive Containing 0.03 mg Ethinyl Estradiol and 0.15 mg Levonorgestrel: An Open-Label, Randomized, Crossover Study. Drugs in R&D 13:3, pages 223-233.
Crossref
Crossref
P. This. (2013) Diminuer la fréquence des règles : le point sur la contraception étendue. Gynécologie Obstétrique & Fertilité 41:6, pages 381-387.
Crossref
Crossref
LENE HEE, LAURA OZER KETTNER & MOGENS VEJTORP. (2012) Continuous use of oral contraceptives: an overview of effects and side‐effects. Acta Obstetricia et Gynecologica Scandinavica 92:2, pages 125-136.
Crossref
Crossref
A. Vincent-Rohfritsch, E. Pernin & N. Chabbert-Buffet. (2012) Nouveaut?s en contraception. La Revue Sage-Femme 11:3, pages 150-157.
Crossref
Crossref
A. Vincent-Rohfritsch, E. Pernin & N. Chabbert-Buffet. (2012) Nouveautés en contraception. Journal de Gynécologie Obstétrique et Biologie de la Reproduction 41:2, pages 108-114.
Crossref
Crossref
Héloïse Gronier, Geoffroy Robin, Sophie Catteau-Jonard, Charlotte Sonigo & Brigitte Letombe. 2012. Endocrinologie en Gynécologie et Obstétrique. Endocrinologie en Gynécologie et Obstétrique
169
189
.
Pilar Carrasco‐Garrido, Valentín Hernández Barrera, Rocio Martin‐Lopez, Ana López de Andrés, Jesús Esteban Hernandez & Rodrigo Jiménez‐García. (2011) Increased Use of Oral Contraceptives in Spain: Related Factors and Time Trend, 2003–2006. The Journal of Sexual Medicine 8:2, pages 383-390.
Crossref
Crossref
David Serfaty. 2011. Contraception. Contraception
82
202
.
V. Bertin-Steunou, É. Bouquet, É. Cailliez, M. Tanguy & S. Fanello. (2010) Le médecin généraliste et l’oubli de pilule. Journal de Gynécologie Obstétrique et Biologie de la Reproduction 39:3, pages 208-217.
Crossref
Crossref
Inka Wiegratz. 2009. Klinische Endokrinologie für Frauenärzte. Klinische Endokrinologie für Frauenärzte
249
301
.
Édith Guilbert, Amanda Black, Sheila Dunn, Vyta Senikas, Jocelyn Bérubé, Louise Charbonneau, Édith Guilbert, Mathieu Lebœuf, Carol McConnery, Andrée Gilbert, Catherine Risi, Geneviève Roy, Marc Steben, Marie-Soleil Wagner, Anjali Aggarwal, Margaret Burnett, Victoria J. Davis, William A. Fisher, John Allan Lamont, Elyse Levinsky, Karen MacKinnon, N. Lynne McLeod, Rosana Pellizzari, Marie-Soleil Wagner & Tiffany Wells. (2008) Oubli de doses de contraceptif hormonal: Nouvelles recommandations. Journal of Obstetrics and Gynaecology Canada 30:11, pages 1063-1077.
Crossref
Crossref
Edith Guilbert, Amanda Black, Sheila Dunn, Vyta Senikas, Jocelyn Bérubé, Louise Charbonneau, Édith Guilbert, Mathieu Leboeuf, Carol McConnery, Andrée Gilbert, Catherine Risi, Geneviève Roy, Marc Steben, Marie-Soleil Wagner, Anjali Aggarwal, Margaret Burnett, Victoria J. Davis, William A. Fisher, John Allan Lamont, Elyse Levinsky, Karen MacKinnon, N. Lynne McLeod, Rosana Pellizzari, Marie-Soleil Wagner & Tiffany Wells. (2008) Missed Hormonal Contraceptives: New Recommendations. Journal of Obstetrics and Gynaecology Canada 30:11, pages 1050-1062.
Crossref
Crossref
Iñaki Lete, José Luis Doval, Ezequiel Pérez-Campos, Roberto Lertxundi, Marta Correa, Esther de la Viuda, María Ángeles Gómez, José Vicente González, María Teresa Martínez, Nicolás Mendoza & Javier Robledo. (2008) Self-described impact of noncompliance among users of a combined hormonal contraceptive method. Contraception 77:4, pages 276-282.
Crossref
Crossref
G. Robin, P. Massart & B. Letombe. (2007) La contraception des adolescentes en France en 2007. Gynécologie Obstétrique & Fertilité 35:10, pages 951-967.
Crossref
Crossref
. (2007) REFERENCES. Journal of Obstetrics and Gynaecology Canada 29:7, pages S28-S32.
Crossref
Crossref
Yael Swica. (2007) The Transdermal Patch and the Vaginal Ring: Two Novel Methods of Combined Hormonal Contraception. Obstetrics and Gynecology Clinics of North America 34:1, pages 31-42.
Crossref
Crossref
Antoni Serra-Torres, Margarita Montaner-Amor?s, Salvador Sitjar-Mart?nez de Sas, Antoni Sis?-Almirall, Montserrat Espanyol-Navarro & Meritxell Devant-Altimir. (2007) Anticoncepci?n de emergencia: evaluaci?n de los conocimientos de las mujeres, un requisito para la efectividad del tratamiento. Atenci?n Primaria 39:2, pages 87-91.
Crossref
Crossref
David F. Archer. (2006) Menstrual-cycle-related symptoms: a review of the rationale for continuous use of oral contraceptives. Contraception 74:5, pages 359-366.
Crossref
Crossref
Gina S Sucato & Kelly L Gerschultz. (2005) Extended cycle hormonal contraception in adolescents. Current Opinion in Obstetrics & Gynecology 17:5, pages 461-465.
Crossref
Crossref
Alison Edelman, Maria F Gallo, Jeffrey T. Jensen, Mark D. Nichols & David A Grimes. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.